Marilyn Ader, PhD, received her doctorate in physiology and biophysics from the University of Southern California and her master’s in biological sciences from Kent State University. Ader has performed basic and translational research in diabetes and obesity for more than 30 years with particular emphasis on the mechanisms by which multiple organ systems interact to maintain glucose homeostasis, and the role impaired interactions contribute to the pathogenesis of diabetes. She has presented extensively on her basic and clinical studies to elucidate the mechanistic link between atypical antipsychotic treatment, obesity and increased diabetes risk. Ader has served on many NIH grant review committees in the areas of obesity, diabetes, metabolism and antipsychotics. She was co-editor-in-chief of Obesity, the flagship scientific journal of the Obesity Society. She is also the director of the Biomedical Sciences and Translational Medicine Graduate Program at Cedars-Sinai.